Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Hengshan Pharmaceutical is a Chinese pharmaceutical company specializing in the development, manufacture, and sale of finished dosage forms and active pharmaceutical ingredients (APIs). The company produces a wide range of products including antibiotics, antiviral medications, and treatments for cardiovascular and gastrointestinal conditions. With a focus on high-quality manufacturing, it operates facilities that comply with Good Manufacturing Practice (GMP) standards to serve both domestic and international markets. Its portfolio includes well-established generic medications such as amoxicillin, ribavirin, and various vitamin supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Hengshan Pharmaceutical.